Zydus Cadila gets USFDA nod for antihistamine drug
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Cyproheptadine Hydrochloride tablets in the strength of 4 mg, Cadila Healthcare said in a BSE filing. The drug will be produced at the groups formulation manufacturing facility at the pharma SEZ in Ahmedabad.

The tablets are used to relieve allergy symptoms such as hives, watery eyes, sneezing and itching eyes or nose.

http://indiatoday.intoday.in/story/zydus-cadila-gets-usfda-nod-for-antihistamine-drug/1/960729.html
Preview
Like
Comment
Share